EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C6H12O6 |
| Net Charge | 0 |
| Average Mass | 180.156 |
| Monoisotopic Mass | 180.06339 |
| SMILES | OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O |
| WURCS | WURCS=2.0/1,1,0/[a2122h-1b_1-5]/1/ |
| InChI | InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6-/m1/s1 |
| InChIKey | WQZGKKKJIJFFOK-VFUOTHLCSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Daphnia magna (ncbitaxon:35525) | - | Article (Mixtures of similarly acting compounds in Daphnia magna: From gene to metabolite and beyondTine Vandenbrouck, Oliver A.H. Jones, Nathalie Dom, Julian L. Griffin, Wim De CoenEnvironment International 36 (2010) 254-268) | |
| Mus musculus (ncbitaxon:10090) | - | PubMed (19425150) | Source: BioModels - MODEL1507180067 |
| Roles Classification |
|---|
| Biological Roles: | mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). epitope The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. human metabolite Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. anti-obesity agent Any substance which is used to reduce or control weight. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. antibacterial agent A substance (or active part thereof) that kills or slows the growth of bacteria. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antiviral agent A substance that destroys or inhibits replication of viruses. mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. Saccharomyces cerevisiae metabolite Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ). Escherichia coli metabolite Any bacterial metabolite produced during a metabolic reaction in Escherichia coli. antifungal agent An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce. fundamental metabolite Any metabolite produced by all living cells. fundamental metabolite Any metabolite produced by all living cells. |
| Applications: | neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. anti-inflammatory agent Any compound that has anti-inflammatory effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. anticholesteremic drug A substance used to lower plasma cholesterol levels. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anticonvulsant A drug used to prevent seizures or reduce their severity. renoprotective agent Any compound that is able to prevent damage to the kidneys. hypoglycemic agent A drug which lowers the blood glucose level. gastrointestinal drug A drug used for its effects on the gastrointestinal system, e.g. controlling gastric acidity, regulating gastrointestinal motility and water flow, and improving digestion. hyperglycemic agent A drug which increases the blood glucose level. antiinfective agent A substance used in the prophylaxis or therapy of infectious diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| β-D-glucose (CHEBI:15903) has role epitope (CHEBI:53000) |
| β-D-glucose (CHEBI:15903) has role mouse metabolite (CHEBI:75771) |
| β-D-glucose (CHEBI:15903) is a D-glucopyranose (CHEBI:4167) |
| β-D-glucose (CHEBI:15903) is enantiomer of β-L-glucose (CHEBI:37631) |
| Incoming Relation(s) |
| (+)-abscisic acid β-D-glucopyranosyl ester (CHEBI:22151) has functional parent β-D-glucose (CHEBI:15903) |
| (S)-2-trans-abscisic acid β-D-glucopyranosyl ester (CHEBI:62437) has functional parent β-D-glucose (CHEBI:15903) |
| 1-O-(indol-3-ylacetyl)-β-D-glucose (CHEBI:17990) has functional parent β-D-glucose (CHEBI:15903) |
| 1-O-trans-cinnamoyl-β-D-glucopyranose (CHEBI:16279) has functional parent β-D-glucose (CHEBI:15903) |
| 1-O-sinapoyl-β-D-glucose (CHEBI:16546) has functional parent β-D-glucose (CHEBI:15903) |
| 1-thio-β-D-glucopyranose (CHEBI:42896) has functional parent β-D-glucose (CHEBI:15903) |
| 1,2-di-O-sinapoyl-β-D-glucose (CHEBI:27993) has functional parent β-D-glucose (CHEBI:15903) |
| 1,2,6-tris-O-galloyl-β-D-glucose (CHEBI:27395) has functional parent β-D-glucose (CHEBI:15903) |
| 2-(β-D-glucopyranosyloxy)benzoic acid (CHEBI:145663) has functional parent β-D-glucose (CHEBI:15903) |
| 2-deoxy-2-fluoro-β-D-glucose (CHEBI:49128) has functional parent β-D-glucose (CHEBI:15903) |
| 25-acyl-27-norcholesteryl β-D-glucoside (CHEBI:142576) has functional parent β-D-glucose (CHEBI:15903) |
| 3-O-(cis-4-coumaroyl)-β-D-glucopyranose (CHEBI:76093) has functional parent β-D-glucose (CHEBI:15903) |
| 3-O-(trans-4-coumaroyl)-β-D-glucopyranose (CHEBI:76094) has functional parent β-D-glucose (CHEBI:15903) |
| 3-O-sulfo-β-D-glucopyranose (CHEBI:153023) has functional parent β-D-glucose (CHEBI:15903) |
| 3,6-di-O-methyl-β-D-glucose (CHEBI:59473) has functional parent β-D-glucose (CHEBI:15903) |
| 4,6-(1'-carboxyethylidene)-3-O-methyl-β-D-glucopyranose (CHEBI:59362) has functional parent β-D-glucose (CHEBI:15903) |
| 6-O-(trans-4-coumaroyl)-β-D-glucopyranose (CHEBI:76089) has functional parent β-D-glucose (CHEBI:15903) |
| 6-O-(indole-3-acetyl)-β-D-glucose (CHEBI:20685) has functional parent β-D-glucose (CHEBI:15903) |
| 6-O-α-D-glucopyranosyl-D-glucitol (CHEBI:152898) has functional parent β-D-glucose (CHEBI:15903) |
| 7-(β-D-glucosyloxy)indole-3-acetic acid (CHEBI:20774) has functional parent β-D-glucose (CHEBI:15903) |
| abacopterin B (CHEBI:65355) has functional parent β-D-glucose (CHEBI:15903) |
| abacopterin C (CHEBI:65356) has functional parent β-D-glucose (CHEBI:15903) |
| abacopterin D (CHEBI:65357) has functional parent β-D-glucose (CHEBI:15903) |
| bis(β-D-glucosyl) crocetin (CHEBI:62768) has functional parent β-D-glucose (CHEBI:15903) |
| cellobiotol (CHEBI:152395) has functional parent β-D-glucose (CHEBI:15903) |
| eruberin A (CHEBI:140078) has functional parent β-D-glucose (CHEBI:15903) |
| FR207944 (CHEBI:65913) has functional parent β-D-glucose (CHEBI:15903) |
| galloyl β-D-glucose (CHEBI:24183) has functional parent β-D-glucose (CHEBI:15903) |
| gentiobiitol (CHEBI:150274) has functional parent β-D-glucose (CHEBI:15903) |
| isorhamnetin 3-O-β-D-glucopyranoside (CHEBI:75750) has functional parent β-D-glucose (CHEBI:15903) |
| isorhamnetin 7-O-β-D-glucopyranoside (CHEBI:75752) has functional parent β-D-glucose (CHEBI:15903) |
| kaempferol 5-O-β-D-glucopyranoside (CHEBI:75802) has functional parent β-D-glucose (CHEBI:15903) |
| kaempferol 7-O-β-D-glucopyranoside (CHEBI:75790) has functional parent β-D-glucose (CHEBI:15903) |
| licoagroside B (CHEBI:142266) has functional parent β-D-glucose (CHEBI:15903) |
| miserotoxin (CHEBI:6951) has functional parent β-D-glucose (CHEBI:15903) |
| myricetin 3-O-β-D-glucopyranoside (CHEBI:75813) has functional parent β-D-glucose (CHEBI:15903) |
| myricetin 3'-O-β-D-glucopyranoside (CHEBI:75816) has functional parent β-D-glucose (CHEBI:15903) |
| myricetin 7-O-β-D-glucopyranoside (CHEBI:75820) has functional parent β-D-glucose (CHEBI:15903) |
| quercetin 3-O-β-D-glucopyranoside (CHEBI:68352) has functional parent β-D-glucose (CHEBI:15903) |
| quercetin 4'-O-β-D-glucopyranoside (CHEBI:75839) has functional parent β-D-glucose (CHEBI:15903) |
| sambubiose (CHEBI:145629) has functional parent β-D-glucose (CHEBI:15903) |
| staphyloxanthin (CHEBI:71690) has functional parent β-D-glucose (CHEBI:15903) |
| thermozeaxanthin-17 (CHEBI:80207) has functional parent β-D-glucose (CHEBI:15903) |
| tryptophan N-glucoside (CHEBI:76121) has functional parent β-D-glucose (CHEBI:15903) |
| α-D-Galp-(1→4)-β-D-Glcp (CHEBI:148271) has functional parent β-D-glucose (CHEBI:15903) |
| α-D-GlcpNAc-(1→2)-β-D-Glcp (CHEBI:149311) has functional parent β-D-glucose (CHEBI:15903) |
| α-D-GlcpN-(1→1)-β-D-Glcp (CHEBI:154433) has functional parent β-D-glucose (CHEBI:15903) |
| α-D-Xylp-(1→6)-β-D-Glcp (CHEBI:146431) has functional parent β-D-glucose (CHEBI:15903) |
| α-L-Arap-(1→2)-β-D-Glcp (CHEBI:155122) has functional parent β-D-glucose (CHEBI:15903) |
| α-L-Arap-(1→4)-β-D-Glcp (CHEBI:150304) has functional parent β-D-glucose (CHEBI:15903) |
| α-L-Arap-(1→6)-β-D-Glcp (CHEBI:145634) has functional parent β-D-glucose (CHEBI:15903) |
| α-L-Fucp-(1→2)-β-D-Glcp (CHEBI:154750) has functional parent β-D-glucose (CHEBI:15903) |
| α-L-Fucp-(1→3)-β-D-Glcp (CHEBI:146899) has functional parent β-D-glucose (CHEBI:15903) |
| α-L-Fucp-(1→6)-β-D-Glcp (CHEBI:146625) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Galp-(1→2)-β-D-Glcp (CHEBI:154801) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Galp-(1→3)-β-D-Glcp (CHEBI:145603) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-GalpNAc-(1→4)-β-D-Glcp (CHEBI:149146) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→2)-D-Glc-OH (CHEBI:153954) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→2)-D-Xylp (CHEBI:150673) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→2)-β-D-Galf (CHEBI:155241) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-D-Arap (CHEBI:151265) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-D-Galp (CHEBI:155139) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-D-Glc-OH (CHEBI:154588) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-D-GlcpNAc (CHEBI:152894) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-α-D-Galp (CHEBI:152941) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-α-L-Fucp (CHEBI:150651) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-β-D-Arap (CHEBI:148939) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→3)-β-L-Fucp (CHEBI:156661) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→4)-D-Galp (CHEBI:152811) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→4)-D-Xylp (CHEBI:148105) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→4)-α-L-Arap (CHEBI:152976) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→4)-α-L-Fucp (CHEBI:151502) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→4)-β-D-Galp (CHEBI:154052) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→4)-β-D-GlcpNAc (CHEBI:150380) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→4)-β-D-Xylp (CHEBI:153729) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→5)-D-Xylf (CHEBI:154967) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→5)-β-D-Xylf (CHEBI:151762) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→6)-α-D-Galp (CHEBI:153179) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Glcp-(1→6)-β-D-Galp (CHEBI:155706) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-glucosamine (CHEBI:28393) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-glucose 1-phosphate (CHEBI:16218) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-glucose 6-phosphate (CHEBI:17719) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-glucoside (CHEBI:22798) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-glucosyl crocetin (CHEBI:62765) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Xylf-(1→6)-β-D-Glcp (CHEBI:151964) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Xylp-(1→3)-β-D-Glcp (CHEBI:152426) has functional parent β-D-glucose (CHEBI:15903) |
| β-D-Xylp-(1→4)-β-D-Glcp (CHEBI:146845) has functional parent β-D-glucose (CHEBI:15903) |
| β-L-Fucp-(1→2)-β-D-Glcp (CHEBI:153969) has functional parent β-D-glucose (CHEBI:15903) |
| β-L-glucose (CHEBI:37631) is enantiomer of β-D-glucose (CHEBI:15903) |
| β-D-glucosyl group (CHEBI:30697) is substituent group from β-D-glucose (CHEBI:15903) |
| IUPAC Name |
|---|
| β-D-glucopyranose |
| Synonyms | Source |
|---|---|
| beta-D-Glucose | KEGG COMPOUND |
| BETA-D-GLUCOSE | PDBeChem |
| D-gluco-Hexose | ChEBI |
| UniProt Name | Source |
|---|---|
| β-D-glucose | UniProt |
| Citations |
|---|